Cargando…
p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor
Neuroblastomas are one of the most common types of solid tumors in infants and children and are responsible for approximately 15% of childhood cancer deaths. Neuroblastomas rarely have mutations in p53, with less than 2% of NB containing mutations in p53, compared to up to 60% for other tumor classe...
Autores principales: | Levesque, Aime A., Pappalardo, Rebecca M., Puli, Pawan, Enzor, Laura A., Angeles, Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830664/ https://www.ncbi.nlm.nih.gov/pubmed/35143532 http://dx.doi.org/10.1371/journal.pone.0263463 |
Ejemplares similares
-
Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells
por: Osborne, Hugh C., et al.
Publicado: (2022) -
Suppression of HSF1 activity by wildtype p53 creates a driving force for p53 loss-of-heterozygosity
por: Isermann, Tamara, et al.
Publicado: (2021) -
Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis
por: Chen, Zhenghu, et al.
Publicado: (2016) -
Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents
por: Michaelis, M, et al.
Publicado: (2012) -
The Status of p53 Oligomeric and Aggregation States in Cancer
por: de Oliveira, Guilherme A. P., et al.
Publicado: (2020)